Benbing Chun Ruanjiaonang (苯丙醇软胶囊)苯丙醇软胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 广州白云山星群(药业)股份有限公司Chinese legal name: 广州白云山星群(药业股份有限公司)
主要成分Active Ingredients
- 齐墩果酸粗品Qidun Guosuan Cupin
- 云芝多糖Yunzhi Duotang
药物知识说明
齐墩果酸粗品是一种在国家药监局注册认定的药品。该药品含有云芝多糖、齐墩果酸粗品-601dabed等成分。
该药品关联的活性成分包括：云芝多糖Yunzhi Duotang、齐墩果酸粗品Qidun Guosuan Cupin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：广州白云山星群(药业)股份有限公司Chinese legal name: 广州白云山星群(药业股份有限公司)。
您可以探索含有相同成分的其他药品：云芝多糖-01d0ba4b成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 苯丙醇软胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 云芝多糖Yunzhi Duotang, 齐墩果酸粗品Qidun Guosuan Cupin.
Manufacturers recorded for this product: 广州白云山星群(药业)股份有限公司Chinese legal name: 广州白云山星群(药业股份有限公司).
Explore other medicines containing the same ingredient: 云芝多糖 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 苯丙醇软胶囊Recorded Chinese name: 苯丙醇软胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.2g0.2 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 广州白云山星群(药业)股份有限公司Chinese legal name: 广州白云山星群(药业股份有限公司)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H44023172
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H44023172
Manufacturer
Chinese legal name: 广州白云山星群(药业)股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H44023172
生产企业
广州白云山星群(药业)股份有限公司(国产)
适应症
本品具有降酶，降浊，调整机体免疫功能，改善代谢障碍、肝病症状及加速肝功能恢复等作用。用于急、慢性肝炎。
用法用量
口服给药：每次0.1～0.2g，每天3次，餐后服。急性病例，可酌情递增至每次0.2g，每天4次。如治疗超过3周，每天剂量不宜超过0.1～0.2g。
不良反应
偶有胃部不适,减量或停药后消失。
禁忌
对本品过敏者、胆道阻塞性、黄疽患者禁用。
注意事项
1、如应用本品超过3周，每日剂量不宜超过2粒。
2、妊娠期头三个月慎用。
3、儿童用量请咨询医师或药师。
4、如服用过量或出现严重不良反应,请立即就医。
5、当药品性状发生改变时禁止服用。
6、儿童必须在成人监护下使用。
7、请将此药品放在儿童不能接触的地方。
贮藏
密封，置阴凉处。
规格
0.2g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.